0001209191-16-153182.txt : 20161202 0001209191-16-153182.hdr.sgml : 20161202 20161202194028 ACCESSION NUMBER: 0001209191-16-153182 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161130 FILED AS OF DATE: 20161202 DATE AS OF CHANGE: 20161202 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUIDEL CORP /DE/ CENTRAL INDEX KEY: 0000353569 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 942573850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12544 HIGH BLUFF DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 8585521100 MAIL ADDRESS: STREET 1: 12544 HIGH BLUFF DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: MONOCLONAL ANTIBODIES INC /DE/ DATE OF NAME CHANGE: 19910210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bujarski Robert Joseph CENTRAL INDEX KEY: 0001333458 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-10961 FILM NUMBER: 162032452 MAIL ADDRESS: STREET 1: C/O QUIDEL CORPORATION STREET 2: 12544 HIGH BLUFF DRIVE, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-11-30 0 0000353569 QUIDEL CORP /DE/ QDEL 0001333458 Bujarski Robert Joseph 12544 HIGH BLUFF DRIVE, SUITE 200 SAN DIEGO CA 92130 0 1 0 0 SVP, Bus Dev & Gen Counsel Common Stock 2016-11-30 4 M 0 15000 17.38 A 74896 D Common Stock 2016-11-30 4 S 0 15000 22.7794 D 59896 D Common Stock 2016-11-30 4 M 0 12943 17.38 A 72839 D Common Stock 2016-11-30 4 S 0 12943 22.7853 D 59896 D Common Stock 2016-11-30 4 M 0 4057 15.28 A 63953 D Common Stock 2016-11-30 4 S 0 4057 22.7853 D 59896 D Common Stock 2016-11-30 4 M 0 7288 15.28 A 67184 D Common Stock 2016-11-30 4 S 0 7288 23.00 D 59896 D Common Stock 2016-11-30 4 S 0 5000 22.7794 D 54896 D Common Stock 2016-11-30 4 S 0 8000 22.7853 D 46896 D Common Stock 2016-11-30 4 S 0 5000 23.00 D 41896 D Common Stock 2016-12-01 4 M 0 2712 15.28 A 44608 D Common Stock 2016-12-01 4 S 0 2712 23.00 D 41896 D Non-Qualified Stock Option 17.38 2016-11-30 4 M 0 15000 0.00 D 2012-06-09 2018-06-09 Common Stock 15000 12943 D Non-Qualified Stock Options 17.38 2016-11-30 4 M 0 12943 0.00 D 2012-06-09 2018-06-09 Common Stock 12943 0 D Non-Qualified Stock Options 15.28 2016-11-30 4 M 0 4057 0.00 D 2014-01-18 2020-01-18 Common Stock 4057 16225 D Non-Qualified Stock Options 15.28 2016-11-30 4 M 0 7288 0.00 D 2014-01-18 2020-01-18 Common Stock 7288 8937 D Non-Qualified Stock Options 15.28 2016-12-01 4 M 0 2712 0.00 D 2014-01-18 2020-01-18 Common Stock 2712 6225 D The weighted average sale price for these transactions was $22.7794 per share, with a range of $22.40 to $22.99 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price. The weighted average sale price for these transactions was $22.7853 per share, with a range of $22.50 to $22.995 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price. All transactions reported in this Form 4 were effected pursuant to a pre-established 10b5-1 trading plan. Robert J. Bujarski 2016-12-02